Received Aug 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
rashes; Initial information received on 04-Aug-2025 regarding an unsolicited valid non-serious case received from patient. This case involves an unknown age female patient who had rashes after receiving vaccine diphtheria, tetanus and acellular pertussis vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received unknown dose of suspect diphtheria, tetanus and acellular pertussis vaccine produced by unknown manufacturer (Unknown strength, formulation lot and expiry date) via unknown route in unknown administration site for Immunization. Information on the batch number was requested corresponding to the one at time of event occurrence. On an unknown date the patient developed rashes (rash) (unknown latency) following the administration of diphtheria and tetanus and acellular pertussis vaccine. Reportedly, Patient stated that 13 years ago, they received Tdap in the ER and they experienced rashes and it was reported. It was a Sanofi vaccine. It's been a while, so they should have another Tdap. In the meantime, they were diagnosed with celiac disease, so they wanted to know if there is any gluten-derived ingredient in the Sanofi vaccine. Action taken was not applicable. It was not reported if the patient received corrective treatment for the event. At time of reporting, the outcome was Unknown for the event.